申请人:Takeda Pharmaceutical Company Limited
公开号:US10059713B2
公开(公告)日:2018-08-28
The present invention provides compounds of formula (I) (Formula (I)) and pharmaceutically acceptable salts thereof, wherein Q, X % X4, X5 X6, X7, R1, R2, R3 and R8 are as defined in the specification, processes for the preparation of such compounds, pharmaceutical compositions containing them and the use of such compounds in therapy.
本发明提供了式(I)化合物(式(I))及其药学上可接受的盐,其中Q、X % X4、X5 X6、X7、R1、R2、R3和R8如说明书中所定义;本发明还提供了制备此类化合物的工艺、含有此类化合物的药物组合物以及此类化合物在治疗中的用途。